Peng Wu

Affiliations: 
Chemical Genomics Max Planck Institute for Molecular Physiology 
Google:
"Peng Wu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Qiu X, Kemker C, Goebel GL, et al. (2025) Phenylpyrazoles as Inhibitors of the mA RNA-Binding Protein YTHDF2. Jacs Au. 5: 618-630
Azam U, Humayun WA, Avathan Veettil AK, et al. (2025) Identification of 5-amino-1,3,4-thiadiazole appended isatins as bioactive small molecules with polypharmacological activities. Rsc Medicinal Chemistry
Zhang A, Ou M, Wu P, et al. (2024) Coupled Effect of Nutritional Food Molecules and Surface Protein Interaction on the Bacterial Gastrointestinal Tolerance. Foods (Basel, Switzerland). 13
Jiang M, Giannino N, Goebel GL, et al. (2024) LIN28-Targeting Chromenopyrazoles and Tetrahydroquinolines Induced Cellular Morphological Changes and Showed High Biosimilarity with BRD PROTACs. Chemmedchem. e202400547
Wu W, Lan W, Jiao X, et al. (2024) Mechanisms underlying the therapeutic effects of Gang Huo Qing wen granules in the treatment of influenza based on network pharmacology, molecular docking and molecular dynamics. Scientific Reports. 14: 15853
Brenk R, Wu P, Duca M. (2024) Introduction to the themed collection on 'Targeting RNA with small molecules'. Rsc Medicinal Chemistry. 15: 1796-1797
Goebel GL, Giannino N, Lampe P, et al. (2024) Profiling Cellular Morphological Changes Induced by Dual-targeting PROTACs of Aurora Kinase and RNA-binding Protein YTHDF2. Chembiochem : a European Journal of Chemical Biology. e202400183
Liu Y, Goebel GL, Kanis L, et al. (2024) Aminothiazolone Inhibitors Disrupt the Protein-RNA Interaction of METTL16 and Modulate the mA RNA Modification. Jacs Au. 4: 1436-1449
Wu P, Du H, Yan Y, et al. (2024) Guided diffusion for molecular generation with interaction prompt. Briefings in Bioinformatics. 25
Mushtaq A, Wu P, Naseer MM. (2023) Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets. Pharmacology & Therapeutics. 254: 108579
See more...